[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"erythropoietin-resistant-anemia-epo-resistant-anemia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:erythropoietin-resistant-anemia-epo-resistant-anemia":23},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":4},"100591694","evaluation-of-erythropoietin-therapy-in-patients-with-end-stage-kidney-disease-on-regular-hemodialysis-hemoglobin-outcomes-and-metabolic-syndrome-as-a-risk-factor-for-erythropoietin-resistance--100591694",false,"NCT06983756","\" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance \"","Inclusion Criteria:\n\n* Patients (and replacements) will be randomly selected by a raffle.\n* All participants should be 18 years of age or older and agree to participate in the study after due clarification.\n* Patients with end stage kidney disease (ESKD) on regular hemodialysis for more than 3 months.\n\nExclusion Criteria:\n\n* \\- Patients with neoplasm, severe cardiovascular, cerebrovascular and liver diseases.\n* Females with polycystic ovarian syndrome, those on hormonal replacement therapy and pregnant women.\n* Patients with infection or autoimmune diseases.","ALL","18 Years",{"count":18,"type":19},66,"ESTIMATED","OBSERVATIONAL","The primary aim of this study is to investigate the association between metabolic syndrome and erythropoietin resistance in patients with End-Stage Kidney Disease (ESKD).",[23],"Erythropoietin Resistant Anemia (EPO Resistant Anemia)","NOT_YET_RECRUITING","2025-05-14",{"date":27,"type":28},"2025-05-21","ACTUAL",{"date":30,"type":19},"2025-06-01",{"date":32,"type":19},"2026-01-01",{"name":34,"class":35},"Fayoum University","OTHER"]